We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Udg Healthcare Public Limited Company | LSE:UDG | London | Ordinary Share | IE0033024807 | ORD EUR0.05 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,079.00 | 1,078.00 | 1,079.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMUDG TIDMBARC
Ap19
FORM 8.3 - Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC. Company dealt in UDG HEALTHCARE PLC Class of relevant security to which the ORD dealings being disclosed relate (Note 2) Date of dealing 02 August 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: ORD Long Short Number (%) Number (%) (1) Relevant securities 10,468,904 4.15% 314,657 0.12% (2) Derivatives (other than options): 208,932 0.08% 6,712,467 2.66% (3) Options and agreements to purchase/sell: 0 0.00% 0 0.00% TOTAL: 10,677,836 4.24% 7,027,124 2.79%
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit Purchase 1,121 10.7794 GBP Purchase 3,575 10.7714 GBP Purchase 9,220 10.7728 GBP Purchase 9,979 10.7723 GBP Purchase 20,239 10.7785 GBP Purchase 39,185 10.7707 GBP Purchase 40,998 10.7800 GBP Purchase 3,502,535 10.7700 GBP Sale 665 10.7700 GBP Sale 2,445 10.7682 GBP Sale 2,999 10.7712 GBP Sale 3,475 10.7775 GBP Sale 13,813 10.7744 GBP Sale 18,669 10.7805 GBP Sale 23,292 10.7800 GBP Sale 25,410 10.7710 GBP Sale 54,827 10.7750 GBP Sale 226,771 10.7732 GBP NB: The below transactions which were previously disclosed have been cancelled Class of relevant Purchase/sale Number of relevant Price per unit securities security ORD Sale 226,771 10.7732 GBP
(b) Derivatives transactions (other than options transactions)
Product Name Nature of transaction Number of relevant Price per securities unit SWAP Long 55 10.7690 GBP SWAP Long 1,578 10.7485 GBP CFD Long 2,445 10.7682 GBP CFD Long 3,475 10.7775 GBP SWAP Long 7,705 10.7700 GBP SWAP Long 8,128 10.7794 GBP SWAP Long 12,072 10.7800 GBP CFD Long 17,717 10.7675 GBP SWAP Short 2,514 10.7794 GBP SWAP Short 12,306 10.7735 GBP SWAP Short 24,505 10.7800 GBP CFD Short 65,748 10.7708 GBP
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option money name, selling, securities price e.g. date paid/received e.g. purchasing, to which American, per unit call varying the option European (Note 5) option etc. relates etc. (Note 7)
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5) e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 17 Aug 2021 Contact name: Large Holdings Regulatory Operations Telephone number: 020 3134 7213 If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection
View source version on businesswire.com: https://www.businesswire.com/news/home/20210817005571/en/
CONTACT:
BARCLAYS PLC
SOURCE: BARCLAYS PLC Copyright Business Wire 2021
(END) Dow Jones Newswires
August 17, 2021 08:28 ET (12:28 GMT)
1 Year Udg Healthcare Public Chart |
1 Month Udg Healthcare Public Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions